This inventor holds 2 USPTO granted patents. Top assignee: Troponwerke Dinklage & Company. Active years: 1976-1978.
Location History:
- Cologne, DE (1976)
- Cologne (Mulheim), DE (1978)
Company Filing History:
Years Active: 1976-1978
Title: Otfried Brendler: Innovator in Antiphlogistic Compounds
Introduction
Otfried Brendler is a notable inventor based in Cologne, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antiphlogistic activity. His work has led to the creation of innovative processes that enhance the efficacy of medicinal compounds.
Latest Patents
Brendler holds 2 patents, with his latest focusing on a process for the production of compounds that exhibit antiphlogistic properties. This patent details a method for condensing specific compounds at elevated temperatures in an inert solvent, resulting in products that serve as intermediates for producing indole derivatives. These derivatives are recognized for their outstanding antiphlogistic activity, offering benefits without the side effects commonly associated with traditional pharmaceuticals.
Career Highlights
Otfried Brendler is associated with Troponwerke Dinklage & Company, where he has been instrumental in advancing research and development in pharmaceutical compounds. His innovative approaches have positioned him as a key figure in the industry, contributing to the enhancement of therapeutic options available to patients.
Collaborations
Throughout his career, Brendler has collaborated with esteemed colleagues such as Karl-Heinz Boltze and Peter-Rudolf Seidel. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the advancement of research in their field.
Conclusion
Otfried Brendler's contributions to the development of antiphlogistic compounds highlight his role as an influential inventor in the pharmaceutical industry. His innovative processes and collaborations continue to pave the way for advancements in medical treatments.